Vitamin K1 amplification of benzo(a)pyrene metabolism in chick embryos

Insights

Vitamin K1 (K1) can enhance benzo(a)pyrene (BP) metabolism by increasing arylhydrocarbon hydroxylase (AHH) and cytochrome P-450, potentially aiding BP-induced mutagenicity.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Benzo(a)pyrene (BP) is a polycyclic aromatic hydrocarbon known for its mutagenic and carcinogenic properties.
  • Metabolism of BP involves Phase I (oxidation) and Phase II (conjugation) enzymatic reactions.
  • Chick embryos provide a suitable model for studying xenobiotic metabolism.

Purpose of the Study:

  • To investigate the effect of vitamin K1 (K1) on benzo(a)pyrene (BP) metabolism in chick embryos.
  • To assess the impact of K1 on key enzymes involved in BP detoxification, including arylhydrocarbon hydroxylase (AHH), cytochrome P-450, glutathione (GSH), and glutathione S-transferase (GST).

Main Methods:

  • Seventeen-day-old chick embryos were used as the experimental system.
  • BP was administered via air sac injection.
  • Vitamin K1 was administered 24 hours prior to BP injection.
  • Levels of AHH, cytochrome P-450, GSH, and GST activity in the liver were measured.

Main Results:

  • BP injection led to increased AHH and P-450 levels and decreased GSH levels.
  • Pre-treatment with K1 resulted in decreased GST activity and augmented AHH induction compared to controls.
  • Ubiquinone showed a less significant effect on BP metabolism than K1 at equimolar concentrations.

Conclusions:

  • Vitamin K1 augments BP metabolism (Phase I) and decreases Phase II conjugation, suggesting an adjuvant role in BP-induced mutagenicity and carcinogenicity.
  • K1's effect on BP metabolism is more pronounced than that of ubiquinone.
  • These findings highlight K1's potential role in modulating the toxicological effects of environmental carcinogens.